home I moa I about us I rules & regulations I contact us

Background

Being the member of the executive council of TERMIS-AP (Asia Pacific), Dr. Chandra P Sharma attended the Executive Council meeting of TERMIS at the Regenerate 2006, the World Congress on Tissue Engineering and Regenerative Medicine in Pittsburg on April 24, 2006. Dr. Sharma was given the mandate to start the STERMI as per the letter attached as an appendix 1. He communicated with many scientists in India . Based on the favorable response received the Memorandum of Association and the Rules & Regulations were developed, and a fourteen member committee was organized by Dr. Chandra P. Sharma at BMT Wing of SCTIMST. 

Preamble

The emerging technology of tissue engineering, where a living assembly based on the patients own cells and a delivery scaffold is used to specifically repair diseased or damaged tissue, is the key area for progress in modern health care. Regenerative medicine is likely to involve the implantation of new tissue and or promote regeneration of normal parenchyma in patients with damaged or diseased organs.  Regenerative medicine will result in extended healthy life span, with reduction of morbidity and mortality. With a rapid advancement of material sciences, nanotechnology, molecular and cell biology including stem cell research, it is possible to evolve new strategies in tissue engineering and regenerative medicine. However, the success of this challenging new field of medicine depends on development of a strong interdisciplinary and collaborative platform. In near future it may be possible to repair or replace the damaged tissue in any organ system by appropriate tissue engineering scaffolds containing intelligent system of release of different growth factors in sequential fashion to create an organ specific microenvironment resulting in recruitment and differentiation of stem cells.  Aging damages every part of our body, including our stem cells! Until we can address the root cause of age-related degeneration, we must learn how to regenerate every part of the human organ systems including brain. We must also become capable of reliably preventing and defeating cancer in all its forms.

The fundamental and applied research in this multidisciplinary field is still in its incipient stages in India . The objective of this Society will be, not only to cultivate an atmosphere nationwide for the growth of basic and technological oriented research in tissue engineering and regenerative medicine but also to bring the professionals from various faculties together to improve the quality of their approach in future research. This will be done by communicating to all members, by developing a Society's Newsletter and also by arranging workshop with laboratory demonstrations, where learning and exchange of relevant concepts can be stimulated every year. The members will be encouraged to join and participate in the activities of the Tissue Engineering and Regenerative Medicine International Society (TERMIS).

Objectives

The Society shall assemble and discuss matters of scientific interest and mainly strive to achieve the objectives described below:-

1.   to cultivate an atmosphere nationwide for the growth of basic and technological oriented research in tissue engineering and regenerative medicine

2.   to bring the professionals from various faculties together to improve the quality of their approach in future research.

3.   communicating to all members, by developing a Society's Newsletter and also by arranging workshop with laboratory demonstrations, where learning and exchange of relevant concepts can be stimulated every year.

4.   members will be encouraged to join and participate in the activities of the Tissue Engineering and Regenerative Medicine International Society (TERMIS).

5.   to promote scientific research and development of technologies (biomaterials, biophotonics, bioreactors, cellular constructs, etc.) in the areas of Tissue Engineering and Regenerative Medicine, which help in the treatment of diseases in humans and animals leading to amelioration of pain and suffering.

6.   to be an international leader in identifying and developing platform technologies and intellectual property that will underpin the development of tissue engineering and regenerative therapies.

home I moa I about us I rules & regulations I contact us